Blocking the Notch signaling pathway in donor cells may reduce the risk of graft-versus-host disease after bone marrow transplants, a University of Michigan team reports in the Journal of Clinical Investigation. Targeting a ligand-receptor pair in the Notch signaling pathway prevented the disease in mice and did not cause adverse effects or affect the ability of the transplanted cells to fight cancer, according to the study. The findings open new routes for possible treatments of T cell-related conditions in transplants, an investigator said.
Method could prevent GVHD in bone marrow transplants
SmartBrief Job Listings for Health Care